缩短镰状细胞血管闭塞性危象持续时间的治疗选择:一项系统评价

Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review.

作者信息

Akindele Adebisi O, Jalkh Ana P, Eastmond Aziza K, Shetty Chaitra, Rizvi Syed Muhammad Hannan Ali, Sharaf Joudi, Williams Kerry-Ann D, Tariq Maha, Acharekar Maitri V, Guerrero Saldivia Sara Elena, Unnikrishnan Sumedha N, Chavarria Yeny Y, Balani Prachi

机构信息

Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Internal Medicine, Saint Vincent Hospital, Worcester, USA.

出版信息

Cureus. 2022 Aug 24;14(8):e28337. doi: 10.7759/cureus.28337. eCollection 2022 Aug.

Abstract

Most patients with sickle cell disease (SCD) seek hospital care because of pain symptoms. While some patients opt to treat themselves at home, some prefer to seek treatment in a hospital setting. There are, however, some patients with more complicated effects of the disease who seek treatment so often that they have been termed "super-users." This paper seeks to determine, across the board, the treatments available for vaso-occlusive crisis (VOC), the most common complication of SCD. Due to the frequency and unpredictable nature of VOC, it is no surprise that the lives of so many patients dealing with SCD are constantly disrupted by this complication. Treatments that reduce the frequency of VOC and the need for hospital admissions will help these patients find some semblance of balance in their quality of life.

摘要

大多数镰状细胞病(SCD)患者因疼痛症状而寻求住院治疗。虽然一些患者选择在家自行治疗,但一些患者更喜欢在医院环境中接受治疗。然而,有一些患者病情影响更为复杂,就医频率极高,被称为“超级使用者”。本文旨在全面确定可用于治疗血管闭塞性危机(VOC)的方法,这是SCD最常见的并发症。由于VOC发作频繁且具有不可预测性,毫不奇怪,许多患有SCD的患者的生活经常被这种并发症打乱。减少VOC发作频率和住院需求的治疗方法将有助于这些患者在生活质量上找到某种平衡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbd/9510888/47107468e6a6/cureus-0014-00000028337-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索